Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 401.44 | 215.75 | 82.16 | 105.33 |
Depreciation/ Depletion | 59.70 | 52.78 | 49.04 | 39.68 |
Non- Cash Items | 0.38 | 23.28 | 17.26 | 0.40 |
Changesin Working Capital | -200.34 | -54.59 | -88.08 | 43.94 |
Cashfrom Operating Activities | 261.18 | 237.21 | 60.39 | 189.36 |
Capital Expenditures | -143.67 | -66.13 | -97.69 | -105.40 |
Other Investing Cash Flow Items Total | -6.02 | 4.63 | 2.17 | 20.97 |
Cashfrom Investing Activities | -149.69 | -61.50 | -95.52 | -84.42 |
Financing Cash Flow Items | -14.05 | -13.15 | -13.56 | -18.90 |
Total Cash Dividends Paid | -12.83 | -6.41 | -3.85 | -2.57 |
Issuance( Retirement)of Debt Net | -42.40 | -116.23 | 55.13 | -92.20 |
Cashfrom Financing Activities | -69.28 | -135.80 | 37.72 | -113.66 |
Foreign Exchange Effects | -0.05 | 0.41 | 0.06 | -0.05 |
Net Changein Cash | 42.16 | 40.32 | 2.66 | -8.77 |
Cash Interest Paid | 14.05 | 13.15 | 13.56 | 18.90 |
Cash Taxes Paid | 111.60 | 43.63 | 20.49 | 5.27 |
Neuland Laboratories Dividend Neuland Laboratories Bonus Neuland Laboratories News Neuland Laboratories AGM Neuland Laboratories Rights Neuland Laboratories Splits Neuland Laboratories Board Meetings Neuland Laboratories Key Metrics Neuland Laboratories Shareholdings Neuland Laboratories Profit Loss Neuland Laboratories Balance Sheet Neuland Laboratories Q1 Results Neuland Laboratories Q2 Results Neuland Laboratories Q3 Results Neuland Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks